Haluzik M, Cypryk K, Alvarez A, Lauand F, et al. Efficacy and safety of switching to iGlarLixi from premixed insulins in people with type 2 diabetes: The Soli-SWITCH study. Diabetes Obes Metab 2025 Mar 17. doi: 10.1111/dom.16276.
PMID: 40098261